• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性对预测乳腺癌风险检测的偏好——一项离散选择实验

Women's preferences for testing to predict breast cancer risk - a discrete choice experiment.

作者信息

Wang Yi, Ho Peh Joo, Mou Langming, Li Jingmei

机构信息

Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, 117549, Republic of Singapore.

Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Republic of Singapore.

出版信息

J Transl Med. 2025 Jan 21;23(1):96. doi: 10.1186/s12967-025-06119-9.

DOI:10.1186/s12967-025-06119-9
PMID:39838430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11753052/
Abstract

BACKGROUND

Risk-based breast cancer screening offers a more targeted and potentially cost-effective approach in cancer detection compared to age-based screening. This study aims to understand women's preferences and willingness for undergoing risk assessment tests.

METHODS

A discrete choice experiment (DCE) was conducted. Six attributes were selected to construct the DCE questionnaire: one-time cost of the test, methods for reducing late-stage breast cancer, annual breast cancer screening expenses, insurance coverage for early-stage breast cancer, family risk correlation, and risk communication methods. Women aged between 21 and 59 were recruited from Singapore. Latent class analysis was performed.

RESULTS

Three hundred twenty-eight women were included in the analysis and classified into two classes: test supporters and non-supporters. Both classes prioritised test costs and screening costs. Among non-cost attributes, the potential to reduce late-stage breast cancer diagnosis was the most influential factor. Insurance coverage increased willingness to undergo testing. Risk communication methods were not significant in influencing the decision of undergoing tests. Non-supporters were less inclined to take the test if family risk correlation was high. Younger women, married women, full-time employees, and those with a history of breast disease were more likely to be supporters. Women with a family history of breast cancer were more likely to be non-supporters.

CONCLUSIONS

Financial incentives play a notable role in increasing the uptake of risk-prediction tests. However, the programme's success depends on understanding and addressing the diverse preferences of women. While cost considerations ranked highly, additional strategies are needed to engage groups that are hesitant, particularly those with a high family risk correlation.

摘要

背景

与基于年龄的筛查相比,基于风险的乳腺癌筛查在癌症检测方面提供了一种更具针对性且可能更具成本效益的方法。本研究旨在了解女性对接受风险评估测试的偏好和意愿。

方法

进行了一项离散选择实验(DCE)。选择六个属性来构建DCE问卷:测试的一次性成本、降低晚期乳腺癌的方法、年度乳腺癌筛查费用、早期乳腺癌的保险覆盖范围、家族风险相关性以及风险沟通方法。从新加坡招募年龄在21至59岁之间的女性。进行了潜在类别分析。

结果

328名女性被纳入分析并分为两类:测试支持者和非支持者。两类都将测试成本和筛查成本列为优先考虑因素。在非成本属性中,降低晚期乳腺癌诊断的可能性是最具影响力的因素。保险覆盖范围增加了接受测试的意愿。风险沟通方法在影响接受测试的决定方面并不显著。如果家族风险相关性高,非支持者不太倾向于接受测试。年轻女性、已婚女性、全职员工以及有乳腺疾病史的女性更有可能成为支持者。有乳腺癌家族史的女性更有可能成为非支持者。

结论

经济激励在提高风险预测测试的接受度方面发挥着显著作用。然而,该计划的成功取决于理解和满足女性的不同偏好。虽然成本考虑排名很高,但需要额外的策略来吸引犹豫不决的群体,特别是那些家族风险相关性高的群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c47/11753052/7887a461bb18/12967_2025_6119_Figb_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c47/11753052/f0e19a20860b/12967_2025_6119_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c47/11753052/7887a461bb18/12967_2025_6119_Figb_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c47/11753052/f0e19a20860b/12967_2025_6119_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c47/11753052/7887a461bb18/12967_2025_6119_Figb_HTML.jpg

相似文献

1
Women's preferences for testing to predict breast cancer risk - a discrete choice experiment.女性对预测乳腺癌风险检测的偏好——一项离散选择实验
J Transl Med. 2025 Jan 21;23(1):96. doi: 10.1186/s12967-025-06119-9.
2
Advancing Colorectal Cancer Detection With Blood-Based Tests: Qualitative Study and Discrete Choice Experiment to Elicit Population Preferences.通过血液检测推进结直肠癌检测:定性研究和离散选择实验以引出人群偏好。
JMIR Public Health Surveill. 2024 Jul 17;10:e53200. doi: 10.2196/53200.
3
Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?探究女性对乳腺癌筛查偏好的异质性:风险沟通是否重要?
Value Health. 2018 Feb;21(2):219-228. doi: 10.1016/j.jval.2017.07.010. Epub 2017 Sep 1.
4
Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.乳腺癌筛查中女性的益处与危害权衡:离散选择实验的结果
Value Health. 2018 Jan;21(1):78-88. doi: 10.1016/j.jval.2017.07.003. Epub 2017 Aug 18.
5
What Breast Cancer Screening Program do Rural Women Prefer? A Discrete Choice Experiment in Jiangsu, China.农村妇女更喜欢哪种乳腺癌筛查项目?来自中国江苏的离散选择实验。
Patient. 2024 Jul;17(4):363-378. doi: 10.1007/s40271-024-00684-9. Epub 2024 Mar 14.
6
Preferences for breast cancer screening: Results of a discrete choice experiment.乳腺癌筛查偏好:一项离散选择实验的结果
Public Health. 2025 Mar;240:33-40. doi: 10.1016/j.puhe.2025.01.010. Epub 2025 Jan 23.
7
Risk-Adapted Breast Screening for Women at Low Predicted Risk of Breast Cancer: An Online Discrete Choice Experiment.基于风险的乳腺癌低预测风险女性乳房筛查:一项在线离散选择实验。
Med Decis Making. 2024 Jul;44(5):586-600. doi: 10.1177/0272989X241254828. Epub 2024 Jun 3.
8
Preferences for interventions designed to increase cervical screening uptake in non-attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial.偏好设计干预措施以增加未就诊年轻女性的宫颈筛查参与度:一项离散选择实验的结果与一项试验中的观察行为相比如何。
Health Expect. 2020 Feb;23(1):202-211. doi: 10.1111/hex.12992. Epub 2019 Oct 28.
9
Women's preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment.女性对单核苷酸多态性基因检测以指导个性化乳腺癌筛查策略的偏好、支付意愿及预测接受度:一项离散选择实验
Patient Prefer Adherence. 2018 Sep 18;12:1837-1852. doi: 10.2147/PPA.S171348. eCollection 2018.
10
How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.基于早期乳腺癌基因表达谱的化疗治疗决策中,女性如何权衡收益与风险?一项离散选择实验。
BMJ Open. 2016 Jun 2;6(6):e010981. doi: 10.1136/bmjopen-2015-010981.

引用本文的文献

1
Calculating willingness-to-pay with discrete cost and random coefficients in discrete choice experiments.在离散选择实验中使用离散成本和随机系数计算支付意愿。
Health Econ Rev. 2025 Jul 18;15(1):63. doi: 10.1186/s13561-025-00658-z.

本文引用的文献

1
Advancing Colorectal Cancer Detection With Blood-Based Tests: Qualitative Study and Discrete Choice Experiment to Elicit Population Preferences.通过血液检测推进结直肠癌检测:定性研究和离散选择实验以引出人群偏好。
JMIR Public Health Surveill. 2024 Jul 17;10:e53200. doi: 10.2196/53200.
2
Public Preferences for Genetic and Genomic Risk-Informed Chronic Disease Screening and Early Detection: A Systematic Review of Discrete Choice Experiments.公众对基于遗传和基因组风险信息的慢性病筛查及早期检测的偏好:离散选择实验的系统评价
Appl Health Econ Health Policy. 2025 May;23(3):395-408. doi: 10.1007/s40258-024-00893-1. Epub 2024 Jun 25.
3
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?
他莫昔芬剂量降级:降低不良反应的有效策略?
Drugs. 2024 Apr;84(4):385-401. doi: 10.1007/s40265-024-02010-x. Epub 2024 Mar 14.
4
Preferences for Genetic Testing to Predict the Risk of Developing Hereditary Cancer: A Systematic Review of Discrete Choice Experiments.遗传检测预测遗传性癌症风险的偏好:离散选择实验的系统评价。
Med Decis Making. 2024 Apr;44(3):252-268. doi: 10.1177/0272989X241227425. Epub 2024 Feb 7.
5
Most people share genetic test results with relatives even if the findings are normal: Family communication in a diverse population.大多数人会与亲属分享基因检测结果,即便检测结果正常:来自多样化人群的家庭沟通。
Genet Med. 2023 Nov;25(11):100923. doi: 10.1016/j.gim.2023.100923. Epub 2023 Jul 5.
6
Breast cancer risk stratification using genetic and non-genetic risk assessment tools for 246,142 women in the UK Biobank.利用遗传和非遗传风险评估工具对英国生物库 246142 名女性进行乳腺癌风险分层。
Genet Med. 2023 Oct;25(10):100917. doi: 10.1016/j.gim.2023.100917. Epub 2023 Jun 16.
7
"I don't know what I'm feeling for": young women's beliefs about breast cancer risk and experiences of breast awareness.“我不知道自己的感受是什么”:年轻女性对乳腺癌风险的信念和乳房自我意识的体验。
BMC Womens Health. 2023 Jun 16;23(1):312. doi: 10.1186/s12905-023-02441-w.
8
Preferences for Electronic Modes of Communication Among Older Primary Care Patients: Cross-sectional Survey.老年初级保健患者对电子通信方式的偏好:横断面调查
JMIR Form Res. 2023 May 24;7:e40709. doi: 10.2196/40709.
9
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women.低剂量他莫昔芬的副作用:来自健康女性的六臂随机对照试验结果。
Br J Cancer. 2023 Jul;129(1):61-71. doi: 10.1038/s41416-023-02293-z. Epub 2023 May 6.
10
Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.基于人群的前瞻性队列研究:东亚常见癌症的多基因风险评分预测。
Elife. 2023 Mar 27;12:e82608. doi: 10.7554/eLife.82608.